Regeneron tees up myasthenia gravis drug approval after Phase III victory
If approved, the siRNA therapy will enter a highly competitive gMG market dominated by AstraZeneca’s drugs Ultomiris and Soliris.
RemeGen secures telitacicept Phase III win in IgAN, seeks China approval
MSD and Daiichi Sankyo commence Phase III breast cancer therapy trial
China takes lead in CGT trials amid Western funding challenges
Eli Lilly eyes orforglipron approval after Phase III diabetes trial success
Akeso eyes mAb approval after double Phase III win
Analysis
View More
Themes
View MorePatient-centric approaches thrive on wearables and remote access in trials
Experts discuss the use of artificial intelligence (AI) and patient-centric strategies in oncology clinical trials.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
1 of 2
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Pharma’s AI prospects get nudged into the future with EU’s AI act
Are regulators keeping pace with AI adoption in clinical trials?
AI-automated IVF procedures represent a new era in fertility treatment
Eli Lilly and BigHat Biosciences ink AI antibody discovery deal